fda mrna vaccine - Search News

Order byBest matchMost fresh

FDA, COVID and vaccines

FDA expands COVID vaccine warning about possible side effect

The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.

· 2d · on MSN

· 1h

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

· 1d · on MSN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

MIT Technology Review · 12h

· 7h

Here's what to know about the FDA's COVID-19 vaccine changes

· 1d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

· 1d

COVID shots should target newer strains of JN.1 variant in 2025-26 campaign, US FDA advisers say

5hon MSN

Officials have been questioning safety, efficacy of mRNA vaccines. What we know

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

STAT1d

FDA asks mRNA vaccine makers to widen age range for rare heart risk warning

In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA vaccines to widen the age range of boys and young men that their labels say are at risk for a rare side effect causing heart inflammation.

BioSpace9h

FDA Vaccine Advisors Agree on COVID-19 Vaccine as New Framework Looms as ‘Elephant in the Room’

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

1hon MSN

Moderna files application for updated COVID vaccine

Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and Drug Administration.

STAT2d

How do we know mRNA vaccines are safe and effective? An explainer

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

AARP4d

Third COVID Vaccine Gets Approved for Adults 65 and Over

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.